Ownership history in MORGAN STANLEY · 10 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in PROTAGENIC THERAPEUTICS INC (PTIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2 | -15,000 | -100.0% | 0.00% | $2 | $1.30 |
| 2025 Q3 | UNCHANGED | 15,002 | — | 0% | 0.00% | $51K | $3.43 |
| 2025 Q2 | ADDED | 15,002 | +15,001 | +1500100.0% | 0.00% | $55K | $3.65 |
| 2024 Q3 | UNCHANGED | 1 | — | 0% | 0.00% | $1 | $8.78 |
As of 2025 Q4 — sorted by position size